Chapter 13.1 Flashcards

1
Q
  1. State the mechanism of action for the following categories of anti-cancer drugs directly affecting DNA synthesis and function: alkylating agents
A

prevent DNA replication/translation. Cause breaks in DNA chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antitumor antibiotics

A

inhibit transcription and causes breaks in DNA chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

platinum coordination complexes

A

Platinum coordination complexes: inhibit DNA replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

topoisomerase inhibitors

A

key enzyme needed for DNA replication. Drugs will inhibit this enzyme causing breaks in DNA chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

anti-metabolite

A

inhibit DNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. State the mechanism of action of the following anti-cancer drugs directly affecting cell mitosis: vinka alkaloids
A

inhibit formation of microtubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

taxanes

A

inhibit breakdown of microtubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. List the three primary ways that anticancer hormones exert their anti-cancer effects.
A

inhibit production of a hormone
Block or reduce effects of hormone
Inhibit cell growth or induce cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. State why most conventional anticancer drugs exert severe and potentially toxic side effects.
A

most of these drugs do not discriminate between health tissues and cancerous tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Define the term targeted therapy.
A

focus on a specific abnormal trait in the cancer cell that is not present in healthy cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. List the two primary targeted therapies used in the treatment of cancer.
A

monoclonal antibodies and tyrosine kinase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. State the mechanism of action of monoclonal antibodies in the treatment of cancer.
A

cell cloning techniques used to manufacture antibodies that bind to a specific antigen on tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. State the mechanism of action of tyrosine kinase inhibitors.
A

Tyrosine kinase inhibitors: inhibits the tyrosine kinase receptors. Prevents cell division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. State the mechanisms of action of the following immunotherapies used to treat cancer: cytokines
A

directly activate pathways that inhibit cell division, promote cell death. Encourage cytotoxic immune cells to attack cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

monoclonal antibodies.

A

monoclonal antibodies: inhibit proteins that are suppressing the immune cells that normally attack cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Describe the immunotherapy referred to as adoptive cell transfer.
A

adoptive cell transfer: grow patient’s T-cells in lab and reinsert into patient.

17
Q
  1. State how retinoids are used in the therapy of cancer
A

help cells differentiate and replicate at a more normal rate

18
Q
  1. List the common side effects observed with anti-cancer drug therapy.
A

hair loss, GI problems, anemia, fatigue, neurotoxicity, cardiotoxicity, skin rashes

19
Q
  1. State the basis for many of the side effects observed with anti-cancer drug therapy
A

normal cells are also experiencing the same toxic changes as the tumor cells

20
Q
  1. State the basic rationale for using combination chemotherapy regimens
A

This process of combination chemotherapy increases the chance of successfully treating the cancer because of the additive and synergistic effect of each agent

21
Q
  1. Match each of the following anti-cancer agents with its therapeutic category: cyclophosphamide, daunorubicin, cisplatin, etoposide, methotrexate, vincristine, tamoxifene, leuprolide, rituximab, imatinib, interferon alpha-2b.
A
Cyclophosphamide: Akylating agent
Daunorubicin: antitumor antibiotic 
Cisplatin: platinum coordination complex
Etoposide: topoisomerase inhibitor
Methotrexate: antimetabolites
Vincristine: vinka alkaloids
Tamoxifene: antiestrogens
Leuprolide: gonadotropin releaseing hormone drugs
Rituximab: monoclonal antibodies
Imatinib: Tyrosine kinase inhibitors
interferon alpha-2b: cytokine
22
Q
  1. State considerations of a physical therapist working with a patient taking chemotherapy
A

patient support and managing their pain. Exercising. Looking out for side effects